Lobbyist information

Amount

Nicholas Doherty	$90,000.00
Employed Terminated 01/01/2026

Pat Anthony Cerundolo	$150,000.00
Employed Terminated 01/01/2026

Total salaries paid:      $240,000.00

Client information

Amount

Amgen Inc.	$0.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2026 Legislation, regulations, and issues related to biopharmaceuticals, health care, drug pricing, transparency, business, and taxation.

Epic Systems Corporation	$90,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2026 Matters impacting health IT

Gilead Sciences, Inc.	$60,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2026 Any and all matters relating to Gilead Sciences, Inc. including HIV/AIDS, Hepatitis C, oncology, drug pricing policy, and patient access to health care.

Massachusetts Biotechnology Council, Inc.

$90,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2026 Any and all legislation, regulations and policies pertaining to the healthcare system before the legislature or executive branch, including the Offices of the Governor and Lt Governor and all executive offices and agencies of the Commonwealth, the Office of the Attorney General, the Center for Health Information and Analysis, the Health Policy Commission, the Office of Pharmaceutical Policy and Analysis, and the Massachusetts Life Sciences Center, and that concern (a) a biopharmaceutical company's ability to market or sell its products in all sectors and markets in the Commonwealth; (b) patient access to innovative medicines and therapies in the Commonwealth; (c) implementation of Chapter 224 the Acts of 2012 as amended; (d) health care insurance coverage; (e) drug research and development; (f) pharmaceutical recycling, disposal and green bio policies; (g) drug pricing and drug price transparency; (h) the prescribing, dispensing and monitoring of controlled substances; (i) matters before the Massachusetts Life Sciences Center; (j) taxation policies affecting the biopharmaceutical industry; (k) drug safety policies; (j) pharmacy benefit manager practices; (k) the federal 340B program; (l) MassHealth coverage and reimbursement policies; and (m) drug marketing and marketing expense disclosure policies.

Vertex Pharmaceuticals Incorporated	$0.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2026 All legislative and executive budget and/or policy proposals affecting corporate activity in Massachusetts.

Total salaries received:      $240,000.00

Expenditures

Amount